FULGENT GENETICS, INC. Current Assets
FULGENT GENETICS, INC. (FLGT) had Current Assets of $454.77 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-07-30
- 2026-06-30: Assets, Current $454.77M.
- 2026-03-31: Assets, Current $479.04M.
- 2025-12-31: Assets, Current $550.49M.
- 2025-09-30: Assets, Current $507.37M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $454.77M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $479.04M 10-Q · filed 2026-05-01 |
| 2025-12-31 | $550.49M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $507.37M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $428.73M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $416.78M 10-Q · filed 2025-05-02 |
| 2024-12-31 | $353.57M 10-K · filed 2026-02-27 |
| 2024-09-30 | $326.54M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $399.10M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $386.51M 10-Q · filed 2024-05-03 |
| 2023-12-31 | $507.85M 10-K · filed 2025-02-28 |
| 2023-09-30 | $549.86M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $528.29M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $580.72M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $627.87M 10-K · filed 2024-02-28 |
| 2022-09-30 | $696.61M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $675.18M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $765.33M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $611.96M 10-K · filed 2023-02-28 |
| 2021-09-30 | $622.84M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $566.69M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $659.14M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $523.62M 10-K · filed 2022-02-28 |
| 2020-09-30 | $195.62M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $41.18M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $37.02M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $37.08M 10-K · filed 2021-03-08 |
| 2019-09-30 | $39.20M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $34.80M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $36.30M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $39.54M 10-K · filed 2020-03-13 |
| 2018-09-30 | $41.05M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $38.20M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $36.08M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $32.93M 10-K · filed 2019-03-22 |
| 2017-09-30 | $32.04M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $34.73M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $33.17M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $26.14M 10-K · filed 2018-03-20 |
| 2016-09-30 | $17.49M 10-Q · filed 2016-11-14 |
| 2015-12-31 | $2.93M 10-K · filed 2017-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |